Malta - English - Medicines Authority

astellas pharmaceuticals a.e.b.e 6-8 agisilaou str., 151 23 marousi, athens,, greece - tacrolimus - hard capsule - tacrolimus 5 mg - immunosuppressants

Malta - English - Medicines Authority

heaton k.s. na pankraci 14, 140 00 praha 4, czech republic - dutasteride, tamsulosin hydrochloride - hard capsule - dutasteride 0.5 mg tamsulosin hydrochloride 0.4 mg - urologicals

Australia - English - Department of Health (Therapeutic Goods Administration)

gedeon richter australia pty ltd - cariprazine hydrochloride, quantity: 6.54 mg (equivalent: cariprazine, qty 6 mg) - capsule, hard - excipient ingredients: pregelatinised maize starch; magnesium stearate; titanium dioxide; brilliant blue fcf; allura red ac; gelatin; propylene glycol; butan-1-ol; purified water; isopropyl alcohol; shellac; strong ammonia solution; ethanol absolute; iron oxide black; potassium hydroxide - reagila? is indicated for the treatment of schizophrenia in adult patients.

Australia - English - Department of Health (Therapeutic Goods Administration)

gedeon richter australia pty ltd - cariprazine hydrochloride, quantity: 4.905 mg (equivalent: cariprazine, qty 4.5 mg) - capsule, hard - excipient ingredients: pregelatinised maize starch; magnesium stearate; titanium dioxide; brilliant blue fcf; iron oxide yellow; allura red ac; gelatin; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; simethicone; ethanol; shellac; sulfuric acid - reagila? is indicated for the treatment of schizophrenia in adult patients.

Australia - English - Department of Health (Therapeutic Goods Administration)

gedeon richter australia pty ltd - cariprazine hydrochloride, quantity: 3.27 mg (equivalent: cariprazine, qty 3 mg) - capsule, hard - excipient ingredients: pregelatinised maize starch; magnesium stearate; titanium dioxide; brilliant blue fcf; iron oxide yellow; allura red ac; gelatin; propylene glycol; butan-1-ol; purified water; isopropyl alcohol; shellac; strong ammonia solution; ethanol absolute; iron oxide black; potassium hydroxide - reagila? is indicated for the treatment of schizophrenia in adult patients.

Australia - English - Department of Health (Therapeutic Goods Administration)

gedeon richter australia pty ltd - cariprazine hydrochloride, quantity: 1.635 mg (equivalent: cariprazine, qty 1.5 mg) - capsule, hard - excipient ingredients: magnesium stearate; pregelatinised maize starch; titanium dioxide; gelatin; propylene glycol; butan-1-ol; purified water; isopropyl alcohol; shellac; strong ammonia solution; ethanol absolute; iron oxide black; potassium hydroxide - reagila? is indicated for the treatment of schizophrenia in adult patients.

Australia - English - Department of Health (Therapeutic Goods Administration)

vitramed pty ltd - urea (14c), quantity: 37 kbq - capsule, hard - excipient ingredients: citric acid; titanium dioxide; indigo carmine; gelatin - helicap (urea[14c], 37kbq capsule) breath test is indicated for use in the detection of gastric urease as an aid in the diagnosis of h.pylori infection in the human stomach

Australia - English - Department of Health (Therapeutic Goods Administration)

accelagen pty ltd - sunitinib malate, quantity: 50.118 mg (equivalent: sunitinib, qty 37.5 mg) - capsule, hard - excipient ingredients: croscarmellose sodium; mannitol; gelatin; pregelatinised maize starch; titanium dioxide; magnesium stearate; iron oxide yellow; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - sunitinib msn is indicated for;,treatment of advanced renal cell carcinoma (rcc),treatment of gastrointestinal stromal tumour (gist) after failure of imatinib mesilate treatment due to resistance or intolerance,treatment of unresectable, well-differentiated pancreatic neuroendocrine tumours (pancreatic net)

Australia - English - Department of Health (Therapeutic Goods Administration)

accelagen pty ltd - sunitinib malate, quantity: 50.118 mg (equivalent: sunitinib, qty 37.5 mg) - capsule, hard - excipient ingredients: gelatin; iron oxide yellow; pregelatinised maize starch; magnesium stearate; titanium dioxide; croscarmellose sodium; mannitol; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - sunitinib msn is indicated for;,treatment of advanced renal cell carcinoma (rcc),treatment of gastrointestinal stromal tumour (gist) after failure of imatinib mesilate treatment due to resistance or intolerance,treatment of unresectable, well-differentiated pancreatic neuroendocrine tumours (pancreatic net)

Australia - English - Department of Health (Therapeutic Goods Administration)

accelagen pty ltd - sunitinib malate, quantity: 16.706 mg (equivalent: sunitinib, qty 12.5 mg) - capsule, hard - excipient ingredients: croscarmellose sodium; mannitol; gelatin; titanium dioxide; iron oxide red; magnesium stearate; pregelatinised maize starch; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; shellac; ethanol absolute; ammonia; potassium hydroxide - sunitinib msn is indicated for;,treatment of advanced renal cell carcinoma (rcc),treatment of gastrointestinal stromal tumour (gist) after failure of imatinib mesilate treatment due to resistance or intolerance,treatment of unresectable, well-differentiated pancreatic neuroendocrine tumours (pancreatic net)